CORPORATE OPPORTUNITIES FUND INSTITUTIONAL LP's Net Worth
$24 Million
Who is CORPORATE OPPORTUNITIES FUND INSTITUTIONAL LP?
CORPORATE OPPORTUNITIES FUND INSTITUTIONAL LP has an estimated net worth of $24 Million. This is based on reported shares across multiple companies, which include QUESTCOR PHARMACEUTICALS INC, RELM WIRELESS CORP, and Valera Pharmaceuticals Inc.
SEC CIK
CORPORATE OPPORTUNITIES FUND INSTITUTIONAL LP's CIK is 0001246042
Past Insider Trading and Trends
2003 was CORPORATE OPPORTUNITIES FUND INSTITUTIONAL LP's most active year for acquiring shares with 4 total transactions. CORPORATE OPPORTUNITIES FUND INSTITUTIONAL LP's most active month to acquire stocks was the month of August. 2005 was CORPORATE OPPORTUNITIES FUND INSTITUTIONAL LP's most active year for disposing of shares, totalling 8 transactions. CORPORATE OPPORTUNITIES FUND INSTITUTIONAL LP's most active month to dispose stocks was the month of October. 2004 saw CORPORATE OPPORTUNITIES FUND INSTITUTIONAL LP paying a total of $1,166,665.50 for 1,111,110 shares, this is the most they've acquired in one year. In 2005 CORPORATE OPPORTUNITIES FUND INSTITUTIONAL LP cashed out on 4,697,816 shares for a total of $22,225,589.90, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
QUESTCOR PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RELM WIRELESS CORP (BKTI) Snapshot price: $21.17
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -87.07% | -2.58M |
$4.97 | -$12,444,475.60 | 383.55K |
Nov 2 - Nov 3
| |||
Form 4/A
| -4.79% | -130.00K |
$2.77 | -$360,100.00 | 2.58M |
May 25 - Aug 29
| |||
Form 4
| -87.07% | -2.58M |
$4.97 | -$12,444,475.60 | 383.55K |
Nov 2 - Nov 3
| |||
Form 4
| -4.79% | -130.00K |
$2.77 | -$360,100.00 | 2.58M |
May 25 - Aug 29
| |||
Form 4
| +69.32% | 1.11M |
$1.05 | $1,166,665.50 | 2.71M |
May 24 - May 25
| |||
Form 4/A
| +14.00% | 333.33K |
$0.60 | $199,999.80 | 2.71M |
Sep 3
| |||
Form 4
| +14.04% | 334.23K |
$0.60 | $200,539.80 | 2.71M |
Sep 3
| |||
| No matching records found | |||||||||
Valera Pharmaceuticals Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +340.94% | 5.34M |
$4.38 | $21,631,222.35 | 6.91M |
Feb 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||